What is it about?
Exhaled Nitric Oxide measurement (FeNO) is a simple test that has been used for many years in asthma management. It´s not clear yet if FeNO could be of value in COPD. This study is aimed to evaluate if FeNO could detect COPD patients at a higher risk of exacerbations
Why is it important?
For the first time, we demonstrate that COPD patients with persistent high FeNO levels are at a higher risk of moderate and severe COPD exacerbations.
Read the Original
This page is a summary of: Longitudinal measurement of airway inflammation relates to a higher risk of exacerbation in COPD, September 2017, European Respiratory Society (ERS), DOI: 10.1183/1393003.congress-2017.pa399.
You can read the full text:
The following have contributed to this page